Growth Metrics

Lineage Cell Therapeutics (LCTX) Prepaid Assets: 2010-2025

Historic Prepaid Assets for Lineage Cell Therapeutics (LCTX) over the last 15 years, with Sep 2025 value amounting to $1.6 million.

  • Lineage Cell Therapeutics' Prepaid Assets rose 28.17% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 28.17%. This contributed to the annual value of $2.6 million for FY2024, which is 15.88% up from last year.
  • According to the latest figures from Q3 2025, Lineage Cell Therapeutics' Prepaid Assets is $1.6 million, which was up 26.69% from $1.3 million recorded in Q2 2025.
  • Lineage Cell Therapeutics' 5-year Prepaid Assets high stood at $3.2 million for Q3 2021, and its period low was $1.3 million during Q3 2024.
  • Moreover, its 3-year median value for Prepaid Assets was $1.9 million (2025), whereas its average is $1.9 million.
  • Per our database at Business Quant, Lineage Cell Therapeutics' Prepaid Assets spiked by 123.55% in 2021 and then crashed by 48.54% in 2022.
  • Lineage Cell Therapeutics' Prepaid Assets (Quarterly) stood at $2.4 million in 2021, then declined by 22.25% to $1.8 million in 2022, then grew by 20.57% to $2.2 million in 2023, then grew by 15.88% to $2.6 million in 2024, then rose by 28.17% to $1.6 million in 2025.
  • Its Prepaid Assets was $1.6 million in Q3 2025, compared to $1.3 million in Q2 2025 and $1.9 million in Q1 2025.